Zoetis Inc. logo
Zoetis Inc. (ZTS)
Compare

Zoetis Inc. (ZTS) Free Cash Flow Yield: 6.20%

Is Zoetis Inc.’s free cash flow yield high or low?

Zoetis Inc.'s free cash flow yield of 6.20% is 151% above its 5-year average of 2.47%, near the high end of its 5-year range (1.44%–6.81%).

The free cash flow yield for Zoetis Inc. (ZTS) is 6.20% as of Wednesday, June 10, 2026. It is above its 12-month average by 52.49% (4.07%).

ZTS Free Cash Flow Yield Chart

ZTS Free Cash Flow Yield
6.20%+103.28% 1Y
Zoom

ZTS Average Free Cash Flow Yield Chart

ZTS Current vs Average Free Cash Flow Yield Chart

ZTS Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

6.20%

FREE CASH FLOW YIELD AVG TTM

4.07%

FREE CASH FLOW YIELD AVG 3Y

2.90%

FREE CASH FLOW YIELD AVG 5Y

2.47%

FREE CASH FLOW YIELD AVG 10Y

2.41%

FREE CASH FLOW YIELD AVG 15Y

2.39%

FREE CASH FLOW YIELD AVG 20Y

2.39%

CURRENT VS TTM AVG

+52.49%

CURRENT VS 3Y AVG

+114.13%

CURRENT VS 5Y AVG

+151.35%

CURRENT VS 10Y AVG

+157.55%

CURRENT VS 15Y AVG

+159.95%

CURRENT VS 20Y AVG

+159.95%

ZTS Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Zoetis Inc. (ZTS)$34.20B6.20%4.07%2.90%2.47%
Centene Corporation (CNC)$31.94B19.80%15.16%12.35%12.28%
Agilent Technologies, Inc. (A)$37.17B3.36%3.06%3.54%3.21%
Medline Inc. (MDLN)$30.90B5.06%4.78%4.78%4.78%
IQVIA Holdings Inc. (IQV)$30.60B8.58%7.33%5.49%5.07%
DexCom, Inc. (DXCM)$29.24B4.80%3.32%2.08%1.41%
Biogen Inc. (BIIB)$29.00B8.99%9.20%6.93%6.70%
Veeva Systems Inc. (VEEV)$26.73B1.91%3.52%3.07%2.74%
Humana Inc. (HUM)$43.78B2.89%5.40%8.83%7.17%
IDEXX Laboratories, Inc. (IDXX)$44.47B2.37%1.86%1.86%1.65%

Yield Comparison

FCF Yield

6.20%

Earnings Yield

7.40%

Dividend Yield

2.53%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Zoetis Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zoetis Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Zoetis Inc. (ZTS)?
The free cash flow yield for ZTS stock is 6.20%.
Is Zoetis Inc.'s free cash flow yield high or low?
Zoetis Inc.'s free cash flow yield of 6.20% is 151% above its 5-year average of 2.47%, near the high end of its 5-year range (1.44%–6.81%).
What is the TTM average free cash flow yield for Zoetis Inc. (ZTS)?
The TTM average free cash flow yield for ZTS stock is 4.07%.
What is the 3Y average free cash flow yield for Zoetis Inc. (ZTS)?
The 3Y average free cash flow yield for ZTS stock is 2.90%.
What is the 5Y average free cash flow yield for Zoetis Inc. (ZTS)?
The 5Y average free cash flow yield for ZTS stock is 2.47%.
What is the 10Y average free cash flow yield for Zoetis Inc. (ZTS)?
The 10Y average free cash flow yield for ZTS stock is 2.41%.
What is the 15Y average free cash flow yield for Zoetis Inc. (ZTS)?
The 15Y average free cash flow yield for ZTS stock is 2.39%.
What is the 20Y average free cash flow yield for Zoetis Inc. (ZTS)?
The 20Y average free cash flow yield for ZTS stock is 2.39%.

Zoetis Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-106.20%
2026-06-096.15%
2026-06-086.41%
2026-06-056.37%
2026-06-046.36%
2026-06-036.52%
2026-06-026.62%
2026-06-016.52%
2026-05-296.51%
2026-05-286.46%
2026-05-276.36%
2026-05-266.30%
2026-05-226.22%
2026-05-216.32%
2026-05-206.35%
2026-05-196.41%
2026-05-186.51%
2026-05-156.81%
2026-05-146.70%
2026-05-136.80%
2026-05-126.57%
2026-05-116.60%
2026-05-086.11%
2026-05-075.79%
2026-05-064.68%
2026-05-054.63%
2026-05-044.62%
2026-05-014.56%
2026-04-304.53%
2026-04-294.57%
2026-04-284.46%
2026-04-274.42%
2026-04-244.45%
2026-04-234.48%
2026-04-224.43%
2026-04-214.41%
2026-04-204.24%
2026-04-174.25%
2026-04-164.37%
2026-04-154.31%
2026-04-144.30%
2026-04-134.33%
2026-04-104.42%
2026-04-094.34%
2026-04-084.35%
2026-04-074.46%
2026-04-064.40%
2026-04-024.41%
2026-04-014.44%
2026-03-314.40%
2026-03-304.47%
2026-03-274.59%
2026-03-264.46%
2026-03-254.46%
2026-03-244.49%
2026-03-234.52%
2026-03-204.50%
2026-03-194.49%
2026-03-184.44%
2026-03-174.28%
2026-03-164.41%
2026-03-134.50%
2026-03-124.51%
2026-03-114.35%
2026-03-104.32%
2026-03-094.25%
2026-03-064.29%
2026-03-054.26%
2026-03-044.13%
2026-03-034.13%
2026-03-024.04%
2026-02-273.97%
2026-02-264.01%
2026-02-254.04%
2026-02-244.05%
2026-02-234.14%
2026-02-204.04%
2026-02-194.09%
2026-02-184.03%
2026-02-174.15%
2026-02-134.11%
2026-02-124.14%
2026-02-113.93%
2026-02-103.94%
2026-02-093.97%
2026-02-063.97%
2026-02-053.99%
2026-02-043.99%
2026-02-034.13%
2026-02-024.05%
2026-01-304.05%
2026-01-294.15%
2026-01-284.15%
2026-01-274.05%
2026-01-264.08%
2026-01-234.07%
2026-01-224.06%
2026-01-214.04%
2026-01-204.10%
2026-01-164.06%
2026-01-154.03%
2026-01-144.02%
2026-01-134.06%
2026-01-124.03%
2026-01-093.97%
2026-01-083.98%
2026-01-074.02%
2026-01-063.91%
2026-01-053.91%
2026-01-024.01%
2025-12-314.02%
2025-12-304.00%
2025-12-294.01%
2025-12-264.00%
2025-12-244.03%
2025-12-234.09%
2025-12-224.08%
2025-12-194.13%
2025-12-184.12%
2025-12-174.13%
2025-12-164.10%
2025-12-154.18%
2025-12-124.26%
2025-12-114.30%
2025-12-104.28%
2025-12-094.37%
2025-12-084.28%
2025-12-054.26%
2025-12-044.20%
2025-12-034.12%
2025-12-024.06%
2025-12-013.97%
2025-11-283.94%
2025-11-263.96%
2025-11-253.95%
2025-11-244.11%
2025-11-214.14%
2025-11-204.36%
2025-11-194.32%
2025-11-184.28%
2025-11-174.25%
2025-11-144.18%
2025-11-134.17%
2025-11-124.17%
2025-11-114.21%
2025-11-104.22%
2025-11-074.20%
2025-11-064.23%
2025-11-054.19%
2025-11-044.06%
2025-11-033.45%
2025-10-313.46%
2025-10-303.46%
2025-10-293.46%
2025-10-283.43%
2025-10-273.38%
2025-10-243.41%
2025-10-233.40%
2025-10-223.39%
2025-10-213.41%
2025-10-203.43%
2025-10-173.46%
2025-10-163.48%
2025-10-153.51%
2025-10-143.47%
2025-10-133.50%
2025-10-103.53%
2025-10-093.47%
2025-10-083.47%
2025-10-073.49%
2025-10-063.43%
2025-10-033.40%
2025-10-023.40%
2025-10-013.39%
2025-09-303.40%
2025-09-293.48%
2025-09-263.47%
2025-09-253.53%
2025-09-243.52%
2025-09-233.49%
2025-09-223.44%
2025-09-193.41%
2025-09-183.39%
2025-09-173.39%
2025-09-163.38%
2025-09-153.41%
2025-09-123.36%
2025-09-113.31%
2025-09-103.33%
2025-09-093.33%
2025-09-083.28%
2025-09-053.25%
2025-09-043.25%
2025-09-033.27%
2025-09-023.26%
2025-08-293.18%
2025-08-283.22%
2025-08-273.21%
2025-08-263.22%
2025-08-253.21%
2025-08-223.18%
2025-08-213.20%
2025-08-203.18%
2025-08-193.20%
2025-08-183.27%
2025-08-153.23%
2025-08-143.25%
2025-08-133.27%
2025-08-123.33%
2025-08-113.34%
2025-08-083.38%
2025-08-073.36%
2025-08-063.40%
2025-08-053.41%
2025-08-043.35%
2025-08-013.45%
2025-07-313.49%
2025-07-303.42%
2025-07-293.37%
2025-07-283.38%
2025-07-253.35%
2025-07-243.33%
2025-07-233.32%
2025-07-223.37%
2025-07-213.46%
2025-07-183.43%
2025-07-173.39%
2025-07-163.36%
2025-07-153.33%
2025-07-143.27%
2025-07-113.29%
2025-07-103.21%
2025-07-093.22%
2025-07-083.23%
2025-07-073.24%
2025-07-033.20%
2025-07-023.20%
2025-07-013.20%
2025-06-303.26%
2025-06-273.26%
2025-06-263.27%
2025-06-253.24%
2025-06-243.23%
2025-06-233.24%
2025-06-203.24%
2025-06-183.28%
2025-06-173.15%
2025-06-163.10%
2025-06-133.10%
2025-06-123.02%
2025-06-113.06%
2025-06-103.05%
2025-06-093.09%
2025-06-062.99%
2025-06-053.02%
2025-06-043.02%
2025-06-032.99%
2025-06-023.01%
2025-05-303.02%
2025-05-293.05%

Showing the most recent 260 of 3,359 data points. The chart above shows the full history.

About Zoetis Inc.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Parsippany, NJ
13,800 employees
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kristin C. Peck